OCI stock trades near its latest report backdrop

OCI stock is framed by its latest reported financial and market context as investors weigh dated operating metrics, margin trends, and the current share-price setup.

OCI (NL0010558797) is best read through its latest reported numbers and current market setup: the company reported 2025 revenue of USD 5.1 billion, adjusted EBITDA of USD 669 million, and net loss attributable to shareholders of USD 1.1 billion. The stock context now rests on how investors interpret those figures against the listed share base and the most recent trading level.

Revenue, EBITDA, and loss

The 2025 revenue figure of USD 5.1 billion gives the business its scale, while adjusted EBITDA of USD 669 million shows the cash-earnings layer that matters most for a chemicals and fertilizers group. The net loss attributable to shareholders of USD 1.1 billion in 2025 is the clearest comparison point in the set because it contrasts with the positive EBITDA line and underlines the gap between operating profit and bottom-line profit.

That mix matters for OCI stock because investors usually focus first on whether earnings quality, margins, and capital structure move in the same direction. In OCI's case, the contrast between USD 5.1 billion of revenue and USD 1.1 billion of net loss tells a more cautious story than the EBITDA line alone.

What the 2025 mix says

The key interpretation is simple: EBITDA of USD 669 million is not the same as distributable earnings, and the 2025 loss shows why. A market reading of OCI stock therefore depends less on revenue size and more on whether the company can turn its operating base into sustained net profit and cash conversion.

For that reason, the latest report metrics are more useful than broad sector language. Revenue, EBITDA, and net loss from 2025 give a dated frame that investors can compare with future quarters and any new guidance.

OCI products and exposure

OCI's product set spans nitrogen-based fertilizers, industrial products, and related chemical chains, which is why a change in pricing or utilization can flow quickly into reported margins. That business mix helps explain why a revenue figure of USD 5.1 billion can coexist with a net loss of USD 1.1 billion in the same reporting period.

The product angle is relevant because it ties the operating figures to real end markets rather than abstract financial ratios. For OCI stock, the question is how its fertilizer and industrial exposure converts into steadier earnings over the next reporting cycle.

Stock setup and scale

OCI stock remains a large-cap European listing, and the most recent report numbers give the market a clear baseline for valuation work. Without a dated live quote in the available evidence, the cleaner reference point is the 2025 revenue of USD 5.1 billion and adjusted EBITDA of USD 669 million, both of which remain the central published metrics in this article.

That leaves the share narrative anchored to earnings quality rather than a single intraday move. The 2025 net loss of USD 1.1 billion is still the headline figure investors are most likely to compare against any later recovery in operating performance.

Latest operating focus

OCI's reported 2025 results show a company with meaningful operating scale but a still-negative bottom line. The combination of USD 5.1 billion revenue, USD 669 million adjusted EBITDA, and USD 1.1 billion net loss defines the current comparison base for OCI stock.

Investors tracking the name will likely watch whether future updates narrow that gap. If EBITDA improves while the loss shrinks, the reported mix would point to a more durable turnaround than revenue growth alone.

OCI stock facts

• Company: OCI N.V.
• ISIN: NL0010558797
• Ticker: Euronext Amsterdam: OCI
• Trading venue: Euronext Amsterdam
• Sector / Industry: Materials / Chemicals
• Index membership: Not stated in available evidence